M&A Deal Summary

Sirio Pharma Co. Acquires AYANDA & Co. KG

On December 26, 2016, Sirio Pharma Co. acquired life science company AYANDA & Co. KG

Acquisition Highlights
  • This is Sirio Pharma Co.’s 1st transaction in the Life Science sector.
  • This is Sirio Pharma Co.’s 1st transaction in Germany.

M&A Deal Summary

Date 2016-12-26
Target AYANDA & Co. KG
Sector Life Science
Buyer(s) Sirio Pharma Co.
Deal Type Add-on Acquisition

Target

AYANDA & Co. KG

Pritzwalk, Germany
AYANDA GmbH & Co. KG is a vitamin and supplement manufacturer providing private label products for the nutraceutical and dietary supplement industry.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sirio Pharma Co.

Guangdong, China

Category Company
Sector Life Science
DESCRIPTION

Sirio Pharma is a private, closely-held contract manufacturing company in China that produces dietary supplements and drugs.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Germany M&A 1 of 1
Year: 2016 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-13 Treerly Health Co.

Guangzhou, China

Treerly is a Chinese healthcare brand and consists of a portfolio of products uniquely designed to meet women’s nutritional healthcare needs throughout their lives.

Sell -